Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
12-14 August, 2025
Not Confirmed
Not Confirmed
17-21 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
12-14 August, 2025
Industry Trade Show
Not Confirmed
17-21 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
25 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tryngolza-olezarsen-recommended-for-eu-approval-by-chmp-for-familial-chylomicronemia-syndrome-fcs-302513906.html
25 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/25/3121718/0/en/Sobi-Announces-U-S-Food-and-Drug-Administration-Approves-Doptelet-avatrombopag-for-the-Treatment-of-Thrombocytopenia-in-Pediatric-Patients-One-Year-and-Older-with-Persistent-or-Chr.html
16 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sobi-publishes-q2-2025-report-continued-strong-portfolio-and-pipeline-momentum-302506522.html
15 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/the-board-of-directors-of-sobi-exercises-authorisation-for-repurchase-of-shares-for-the-purpose-of-securing-the-companys-commitments-under-incentive-programmes-302505893.html
02 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/invitation-sobis-q2-report-302496717.html
01 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/01/3108202/0/en/Apellis-to-Receive-up-to-300-Million-from-Royalty-Purchase-Agreement-with-Sobi-for-Ex-U-S-Royalties-of-Aspaveli-systemic-pegcetacoplan.html
ABOUT THIS PAGE